Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · IEX Real-Time Price · USD
2.870
-0.130 (-4.33%)
At close: Jul 19, 2024, 4:00 PM
2.940
+0.070 (2.44%)
Pre-market: Jul 22, 2024, 9:02 AM EDT
Kodiak Sciences Employees
Kodiak Sciences had 111 employees as of December 31, 2023. The number of employees decreased by 1 or -0.89% compared to the previous year.
Employees
111
Change (1Y)
-1
Growth (1Y)
-0.89%
Revenue / Employee
n/a
Profits / Employee
-$2,096,847
Market Cap
150.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
High Tide | 1,550 |
Lifecore Biomedical | 459 |
Rani Therapeutics Holdings | 140 |
OptiNose | 132 |
Alpha Tau Medical | 121 |
Vaxart | 109 |
Capricor Therapeutics | 102 |
Assertio Holdings | 53 |
KOD News
- 7 weeks ago - Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences - PRNewsWire
- 2 months ago - Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy - PRNewsWire
- 2 months ago - Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform - PRNewsWire
- 4 months ago - Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire
- 4 months ago - Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024 - PRNewsWire
- 6 months ago - Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting - PRNewsWire
- 7 months ago - Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference - PRNewsWire